MATLIN DAVID J 4
4 · TriSalus Life Sciences, Inc. · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
TriSalus (TLSI) Director David Matlin Receives RSU Awards
What Happened David J. Matlin, a director of TriSalus Life Sciences, was granted a total of 107,669 shares on May 14, 2026 via equity awards reported as acquisitions at $0.00 per share (total reported value $0). The grants break down as: 28,201 RSUs (F1), 23,065 RSUs elected in lieu of board cash retainer (F2), and 56,403 shares reported as a derivative/option-type award (F3). These are awards/vesting grants rather than open-market purchases or sales.
Key Details
- Transaction date: May 14, 2026; filing date: May 15, 2026 (timely).
- Reported price: $0.00 per share; reported total value: $0.
- Grant breakdown: 28,201 RSUs (F1); 23,065 Retainer RSUs (F2); 56,403 derivative/option-type award (F3). Total = 107,669 shares.
- Vesting: F1 RSUs vest in full on May 14, 2027 (one-year cliff). F2 Retainer RSUs vest quarterly in equal one‑third installments through the remainder of 2026. F3 derivative/option fully vests on May 14, 2027 (one-year anniversary).
- Shares owned after the transactions: not specified in the filing.
- No 10b5-1 plan, tax-withholding sale, or late filing noted in the disclosure.
Context These grants are typical director compensation (including an election to take retainer pay as RSUs) and represent future potential equity subject to continued service and vesting schedules. They do not involve immediate cash purchases or sales, and do not by themselves indicate buying or selling sentiment—vesting schedules determine when the shares may be issued.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-14+28,201→ 1,300,145 total - Award
Common Stock
[F2]2026-05-14+23,065→ 1,323,210 total - Award
Director Stock Option (right to buy)
[F3]2026-05-14+56,403→ 121,403 totalExercise: $2.52Exp: 2036-05-13→ Common Stock (56,403 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.
- [F2]Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer.
- [F3]The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer.